ExternalLinks

FDA is urged to move faster to list medicines withdrawn over safety concerns
STAT

In-Depth: How full FDA approval would impact vaccine mandates, competition
ABC-10 News, San Diego

Watchdog calls for probe into 'inappropriate' FDA-Biogen aducanumab collaboration
Fierce Biotech

FDA panels say new arthritis drug too risky
Pain News Network

Carcinogen found in hand sanitizers that plugged COVID gap
The Seattle Times

Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history
STAT

How the bitter political fight over painkillers could derail Biden's FDA pick
Politico

Policy Deciphered: Could FDA inspection backlog lead to approval slowdown?
Medical Marketing and Media

The Alzheimer's approval maze
pharma Manufacturing

Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections
The New York Times

Alzheimer's Association Denies Conflict in Aducanumab Support
Medscape

After a controversial Alzheimer’s drug review, FDA’s Woodcock rejects proposal to ‘firewall’ agency review staff
STAT

Janet Woodcock slams calls for FDA 'firewall' amid aducanumab debacle, citing need for collaborative drug development
Endpoints News

Some retirement communities lure new residents with promise of Covid-19 vaccines
NBC News

FDA’s own documents reveal agency’s lax, slow, and secretive oversight of clinical research
Science

Biogen Alzheimer’s Drug Puts FDA’s Judgment in Harsh Spotlight
Bloomberg

Pfizer's COVID-19 Vax: A Good First Step, Say Experts — But questions remain and some criticize "science by press release"
MedPage Today

'What he is doing is outrageous': Doctors slam Sen. Ron Johnson over hearing on COVID-19 treatments
Milwaukee Journal Sentinel

Our Experts in the News